[Frequency of cardiovascular risk factors and co-morbidity in patients with rheumatic diseases].
Analysis of national data from the health ministry programme of reduction of the cardiovascular risks (2002-2005) shows a high frequency of cardiovascular disease and cardiovascular risk factors in the general population. It is of interest to analyse these data in relation to the practice of rheumatology. In addition, the frequency of cardiovascular pathologies is higher in patients with rheumatoid arthritis and spondylarthropathy. These notions are also very important since these two populations are often treated with non-steroidal anti-inflammatory drugs for a long duration. General knowledge shown in this article concerning the cardiovascular risk factors and co-morbidities in the patients with rheumatic pathologies allows, within the context of a therapeutic decisional strategy in rheumatology, a better estimation of the individual benefit/risk ratio of each prescription and more particularly that of non-steroidal anti-inflammatory drugs.
Bertin
Philippe
P
CHU Dupuytren, Service de Thérapeutique et de Rhumatologie, Limoges.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000453:epidemiology; D002318:Cardiovascular Diseases / Q000453:epidemiology*; D015897:Comorbidity; D005602:France / Q000453:epidemiology; D006801:Humans; D012189:Retrospective Studies; D012216:Rheumatic Diseases / Q000188:drug therapy / Q000453:epidemiology*; D012307:Risk Factors; D025241:Spondylarthritis / Q000188:drug therapy / Q000453:epidemiology
D000894:Anti-Inflammatory Agents, Non-Steroidal